{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:04:11Z","timestamp":1790226251879,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP256f0137005"],"award-info":[{"award-number":["JP256f0137005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The gut microbiome is a potential source of noninvasive cancer biomarkers. We evaluated six fecal microbial markers and developed targeted quantitative PCR (qPCR)-based logistic models for colorectal cancer (CRC) and pancreatic cancer (PC). Using LASSO with the 1-standard-error rule, four markers were selected for CRC (afb, nan, fsr, and 5ar) and three for PC (but, fsr, and saa). In postselection leave-one-out cross-validation of fixed model structures, the CRC and PC models yielded area under the curve (AUCs) of 0.824 and 0.780, respectively. Fixed-model application yielded AUCs of 0.716 for colorectal adenoma and 0.540 for the pancreatic high-risk group. In an exploratory early PC versus high-risk comparison, the fecal qPCR score yielded an AUC of 0.739, compared with 0.543 for CA19-9, although the difference was not statistically significant. Overall, the disease-specific model performance and fixed-model behavior across clinically related groups support further evaluation of model-derived cancer probability scores as exploratory cancer-assessment tools.<\/jats:p>","DOI":"10.1093\/bbb\/zbag090","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:18:14Z","timestamp":1781695094000},"page":"1273-1282","source":"Crossref","is-referenced-by-count":2,"title":["Disease-specific gut microbial signatures generate model-derived cancer probability scores through targeted fecal qPCR profiling"],"prefix":"10.1093","volume":"90","author":[{"given":"Tadashi","family":"Fujii","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]},{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University , Toyoake, Aichi ,","place":["Japan"]},{"name":"BIOSIS Lab. Co., Ltd. , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizaburo","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Nakaoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]},{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University , Toyoake, Aichi ,","place":["Japan"]},{"name":"BIOSIS Lab. Co., Ltd. , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Funasaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[{"name":"Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]},{"name":"Division of Infectious Diseases, University of Pittsburgh School of Medicine , Pittsburgh, PA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hirooka","sequence":"additional","affiliation":[{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University , Toyoake, Aichi ,","place":["Japan"]},{"name":"BIOSIS Lab. Co., Ltd. , Toyoake, Aichi ,","place":["Japan"]},{"name":"Department of Gastroenterology and Hepatology, Fujita Health University Okazaki Medical Center , Okazaki, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Tochio","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]},{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University , Toyoake, Aichi ,","place":["Japan"]},{"name":"BIOSIS Lab. Co., Ltd. , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2026082404522681500_bib1","doi-asserted-by":"publisher","first-page":"e00257","DOI":"10.1128\/jb.00257-22","article-title":"Oral commensal streptococci: gatekeepers of the oral cavity","volume":"204","author":"Baty","year":"2022","journal-title":"J Bacteriol"},{"key":"2026082404522681500_bib2","doi-asserted-by":"publisher","first-page":"107321","DOI":"10.1016\/j.phrs.2024.107321","article-title":"Host-gut microbiota metabolic interactions and their role in precision diagnosis and treatment of gastrointestinal cancers","volume":"207","author":"Cao","year":"2024","journal-title":"Pharmacol Res"},{"key":"2026082404522681500_bib3","doi-asserted-by":"publisher","first-page":"001834","DOI":"10.1099\/jmm.0.001834","article-title":"Levels of 5\u03b1-reductase gene in intestinal lavage fluid decrease with progression of colorectal cancer","volume":"73","author":"Fujii","year":"2024","journal-title":"J Med Microbiol"},{"key":"2026082404522681500_bib4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.9734\/mrji\/2026\/v36i41737","article-title":"Minimally age-dependent gut microbial signatures in pancreatic neoplasia identified by qPCR targeting the but gene","volume":"36","author":"Fujii","year":"2026","journal-title":"Microbiol Res J Int"},{"key":"2026082404522681500_bib5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1574-6941.2009.00671.x","article-title":"Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR","volume":"68","author":"Furet","year":"2009","journal-title":"FEMS Microbiol Ecol"},{"key":"2026082404522681500_bib6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.gastro.2017.09.018","article-title":"Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening","volume":"154","author":"Gies","year":"2018","journal-title":"Gastroenterology"},{"key":"2026082404522681500_bib7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1314119","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N Engl J Med"},{"key":"2026082404522681500_bib8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1128\/AEM.03133-13","article-title":"Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract","volume":"80","author":"Kaci","year":"2014","journal-title":"Appl Environ Microb"},{"key":"2026082404522681500_bib9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41416-024-02794-5","article-title":"Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning","volume":"131","author":"Kawai","year":"2024","journal-title":"Br J Cancer"},{"key":"2026082404522681500_bib10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41575-022-00625-7","article-title":"Microbial signatures in pancreatic cancer","volume":"19","author":"Kotsiliti","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026082404522681500_bib11","doi-asserted-by":"publisher","first-page":"1025136","DOI":"10.3389\/fmicb.2022.1025136","article-title":"Virulence factors of Streptococcus anginosus\u2014a molecular perspective","volume":"13","author":"Kury\u0142ek","year":"2022","journal-title":"Front Microbiol"},{"key":"2026082404522681500_bib12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s12088-024-01340-4","article-title":"Role of gut microbiome in cancer treatment","volume":"64","author":"Mishra","year":"2024","journal-title":"Indian J Microbiol"},{"key":"2026082404522681500_bib13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.9734\/mrji\/2024\/v34i111503","article-title":"Assessment of risk for immune and psychiatric disorders using qPCR-based monitoring of the nan gene in gut microbiota: a non-invasive approach","volume":"34","author":"Nagasaka","year":"2024","journal-title":"Microbiol Res J Int"},{"key":"2026082404522681500_bib14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","article-title":"Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"key":"2026082404522681500_bib15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.9734\/mrji\/2026\/v36i41730","article-title":"Fecal and salivary microbial gene markers for the non-invasive detection of colorectal cancer progression","volume":"36","author":"Nakano","year":"2026","journal-title":"Microbiol Res J Int"},{"key":"2026082404522681500_bib16","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3390\/nu16172889","article-title":"Efficacy of 1-kestose supplementation in patients with pancreatic ductal adenocarcinoma: a randomized controlled pilot study","volume":"16","author":"Nakaoka","year":"2024","journal-title":"Nutrients"},{"key":"2026082404522681500_bib17","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/biomedicines9121897","article-title":"Validation of serum biomarkers that complement CA19-9 in detecting early pancreatic cancer using electrochemiluminescent-based multiplex immunoassays","volume":"9","author":"Song","year":"2021","journal-title":"Biomedicines"},{"key":"2026082404522681500_bib18","doi-asserted-by":"publisher","first-page":"fiad035","DOI":"10.1093\/femsec\/fiad035","article-title":"New gene markers for classification and quantification of Faecalibacterium spp. in the human gut","volume":"99","author":"Tanno","year":"2023","journal-title":"FEMS Microbiol Ecol"},{"key":"2026082404522681500_bib19","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von\u00a0Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"2026082404522681500_bib20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20517\/cdr.2019.10","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"2026082404522681500_bib21","doi-asserted-by":"publisher","first-page":"1598009","DOI":"10.3389\/fphar.2025.1598009","article-title":"Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications","volume":"16","author":"Yang","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026082404522681500_bib22","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Bioscience, Biotechnology, and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bbb\/advance-article-pdf\/doi\/10.1093\/bbb\/zbag090\/68556219\/zbag090.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bbb\/article-pdf\/90\/9\/1273\/68556219\/zbag090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bbb\/article-pdf\/90\/9\/1273\/68556219\/zbag090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:52:33Z","timestamp":1787561553000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bbb\/article\/90\/9\/1273\/8711409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,6,18]]},"published-print":{"date-parts":[[2026,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/bbb\/zbag090","relation":{},"ISSN":["1347-6947"],"issn-type":[{"value":"1347-6947","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,6,18]]}}}